UNITED THERAPEUTICS Corp - 8-K Filing
United Therapeutics reports Q3 2026 revenue of $832.5 million despite a 24% decline in net income. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Exhibits This information shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended)
Tickers: $UTHR